Evidence map›Paper›PMID 34983968›Full record

ReviewNature reviews. Endocrinology2022

Assessment and treatment of thyroid disorders in pregnancy and the postpartum period.

Sun Y Lee, Elizabeth N Pearce

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06527859 (Correlation Between Different Doses of Levothyroxine Supplementation and Peripheral Blood Th17/Treg Balance in Pregnant Women With Normal-high TSH and Positive TPOAb in the First Half of Pregnancy), which is not on this map. Cited by 98 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 4 pooled it
25.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06527859 terminatednot on this map

Correlation Between Different Doses of Levothyroxine Supplementation and Peripheral Blood Th17/Treg Balance in Pregnant Women With Normal-high TSH and Positive TPOAb in the First Half of Pregnancy

TypeobservationalSponsorThird Affiliated Hospital of Zhengzhou UniversityRan2022 to 2024Enrolled64ConditionsPregnancy Related, Thyroid Stimulating, Hormone, CArmsLevothyroxin
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 4 syntheses or guidelines pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Development and Validation of Machine-Learning-Based Prediction Models for Thyroid Diseases During Pregnancy.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  9. Review
  10. Article
  11. Maternal Thyroid Hormone Imbalance and Risk of Autism Spectrum Disorder.The Journal of clinical endocrinology and metabolism · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sun Y LeeSection of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6928-7471
Elizabeth N PearceSection of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, Boston, MA, USA. elizabeth.pearce@bmc.org.ORCID http://orcid.org/0000-0003-3799-0354
Boston University · US

Funding

Effects of maternal thyroid function and thyroidal disruptor exposure on pregnancy and child developmental outcomesK23ES028736 · NIEHS · BOSTON MEDICAL CENTER · PI LEE-MARQUEZ, SUN Y · 2019 to 2023
$1.0M
NIEHS NIH HHS K23 ES028736
6 · The paper itself

Abstract

Thyroid disorders are prevalent in pregnant women. Furthermore, thyroid hormone has a critical role in fetal development and thyroid dysfunction can adversely affect obstetric outcomes. Thus, the appropriate management of hyperthyroidism, most commonly caused by Graves disease, and hypothyroidism, which in iodine sufficient regions is most commonly caused by Hashimoto thyroiditis, in pregnancy is important for the health of both pregnant women and their offspring. Gestational transient thyrotoxicosis can also occur during pregnancy and should be differentiated from Graves disease. Effects of thyroid autoimmunity and subclinical hypothyroidism in pregnancy remain controversial. Iodine deficiency is the leading cause of hypothyroidism worldwide. Despite global efforts to eradicate iodine deficiency disorders, pregnant women remain at risk of iodine deficiency due to increased iodine requirements during gestation. The incidence of thyroid cancer is increasing worldwide, including in young adults. As such, the diagnosis of thyroid nodules or thyroid cancer during pregnancy is becoming more frequent. The evaluation and management of thyroid nodules and thyroid cancer in pregnancy pose a particular challenge. Postpartum thyroiditis can occur up to 1 year after delivery and must be differentiated from other forms of thyroid dysfunction, as treatment differs. This Review provides current evidence and recommendations for the evaluation and management of thyroid disorders in pregnancy and in the postpartum period.

Indexed as

HyperthyroidismPregnancy ComplicationsThyroid DiseasesThyroid NoduleFemaleHumansPostpartum PeriodPregnancy

Identifiers

PMID34983968
PMCPMC9020832
OpenAlexW4205522425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.